Xencor's investigational lupus therapy XmAb5871 fails to meet main goal of mid-stage study https://www.firstwordpharma.com/node/1595539?tsid=28®ion_id=6 …
More From BioPortfolio on "Xencor's investigational lupus therapy XmAb5871 fails to meet main goal of mid-stage study https://www.firstwordpharma.com/node/1595539?tsid=28®ion_id=6 …"